Private
Soligenix released positive preliminary proof-of-concept results on Monday from its collaboration with Axel Lehrer to develop a heat-stable subunit Ebola virus vaccine.
Lehrer is a doctor in the Department of Medicine, Medical Microbiology and Pharmacology at the John A. Burns School of... Read More »
Researchers at the Edgewood Chemical Biological Center (ECBC) and CBI Polymer recently explored how a HydroGel can be modified to decontaminate surfaces contaminated with harmful biological agents, such as the anthrax-inducing Bacillus anthracis.
HydroGel is a biosynthetic polymer that can be... Read More »
The National Institute of Allergy and Infectious Diseases (NIAID) provided BioCryst Pharmaceuticals with additional funding on Monday for efficacy studies of BCX4430 in non-human primates to further assist effective dose regimens.
BCX4430 is a broad-spectrum antiviral that is advancing toward... Read More »
An independent panel of public health, emergency response and communication experts issued a report on Friday on the Ebola epidemic of 2014, identifying recommendations to improve the U.S. Department of Health and Human Services (HHS) response to urgent public health threats.
Concerns... Read More »
The Partnership for Research on Ebola virus in Liberia (PREVAIL) on Monday opened PREVAIL IV, a treatment trial for men who have survived Ebola virus disease (EVD) but continue to have evidence of Ebola virus genetic material - RNA - in their semen.
The trial is sponsored by the National... Read More »
FLIR Systems acquired Armasight, Inc., a leading developer of precision sporting, hunting and military optics products, for approximately $41 million on Wednesday.
"The addition of Armasight to our existing scopes and sights business provides us with meaningful additional scale and injects... Read More »
The National Institutes of Allergy and Infectious Diseases (NIAID) released a report on Tuesday detailing how a single dose of either of two experimental Zika vaccines protected mice infected with the virus for four to eight weeks after receiving the inoculations.
NIAID said that this... Read More »
Lockheed Martin’s Q-53 counter fire radar last week demonstrated its ability to identify and track unmanned aerial systems (UAS) and pass that information to a command and control node.
Lockheed said that this capability will assist forces in a crowded battle space with emerging air threats.... Read More »
Emergent BioSolutions, Inc.’s Center for Innovation in Advanced Development and Manufacturing (CIADM) received a task order on Monday valued at up to $21.9 million from the Biomedical Advanced Research and Development Authority (BARDA) to develop and manufacture a Zika vaccine.
Three cGMP lots... Read More »
The National Institutes of Health (NIH), along with the scientific research organization Fundacao Oswaldo Cruz-Fiocruz, began a multi-country study on Tuesday to evaluate the magnitude of the health risks that Zika virus infection poses on pregnant women and their developing fetuses and infants.... Read More »
The U.S. Department of Health and Human Services (HHS) issued two solicitation notices on Tuesday related to the development and procurement of anthrax vaccines for the Strategic National Stockpile (SNS), a move that Emergent BioSolutions, Inc., said shows the government’s intent to maintain an... Read More »
The U.S. Food and Drug Administration (FDA) completed its Pre-Approval Inspection (PAI) of Emergent BioSolutions, Inc.’s Building 55 for the large-scale manufacturing of BioThrax (anthrax vaccine adsorbed).
Following the PAI’s conclusion, Emergent BioSolutions received a No Action Indicated... Read More »
The Defense Information Systems Agency’s (DISA) Defense Spectrum Organization (DSO) named Alion Science and Technology on Wednesday as an awardee of a five-year, multiple-award contract valued up to $137 million to assist the military’s access to wireless spectrum frequencies.
Alion will... Read More »
Emergent BioSolutions, Inc.’s supplemental Biologics License Application (sBLA) seeking approval for the manufacture of BioThrax (anthrax vaccine adsorbed) at the company’s Building 55 was accepted for review by the U.S. Food and Drug Administration (FDA) this week.
“Emergent’s... Read More »
The U.S. Food and Drug Administration (FDA) granted orphan drug status to Emergent BioSolutions, Inc., on Wednesday for BioThrax (anthrax vaccine adsorbed) for post-exposure prophylaxis of anthrax disease from suspected or confirmed exposure to Bacillus anthraces.
BioThrax is the only... Read More »
Lockheed Martin entered into a partnership with Interset’s insider threat detection solution on Monday.
The decision was announced at the 2016 Gartner Risk and Security Summit conference in National Harbor, MD.
“Insider threats pose one of the highest risks to an organization, and... Read More »
The Los Alamos National Laboratory is holding its annual Robot Rodeo, a competition that tests the abilities of bomb disposal robots from companies throughout the southwest, this week.
“The Robot Rodeo gives bomb-squad teams the opportunity to practice and hone their skills in a lively but... Read More »
Chimerix’s President and CEO M. Michelle Berrey participated in a panel focused on North Carolina’s role in biodefense preparation at the recent “Medical, Biomedical and Biodefense: Support to the Warfighter Symposium.”
"In the event of a smallpox bioweapon event or accidental release,... Read More »
The world-class team of global communications industry leaders that make up a company formed to bid on building the first nationwide 4G LTE broadband wireless network to successfully deliver the FirstNet network for public safety in the U.S. was announced this week.
Rivada Mercury’s group of... Read More »
Science Applications International Corp. (SIAC) was awarded a five-year, multiple-award, indefinite deliver, indefinite quantity contract worth up to $460 million on Wednesday from the General Services Administration (GSA) Federal Systems Integration and Management (FEDSIM) and U.S. Cyber Command... Read More »
With the world’s volume of stored data doubling each year, an opportunity exists for organizations across the globe to analyze that data and use it to add business value, particularly as it relates to defense and cybersecurity, according to Matthew Kuckuk, CGI Group’s data analytics global... Read More »
The U.S. Army Joint Program Executive Office for Chemical and Biological Defense awarded Battelle a $59 million contract on Monday for medical countermeasures to combat infectious diseases affecting warfighters and the general public.
The grant is part of Battelle’s OASIS contract mechanism,... Read More »
Avon Protection on Monday introduced new technology designed to combat chemical, biological, radiological and nuclear (CBRN) threats for first responders and other security-related officers.
One of the new products includes the Avon CSPARR, the newest generation of CBRN powered air purifying... Read More »
Tyco Integrated Security recently unveiled a high-tech security system at Houston’s George Bush Intercontinental Airport to help prevent costly exit lane security breaches and increase operational efficiency.
“Airports will be able to save costs overall by using technology over manpower,”... Read More »
The Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services (HHS), ordered a bulk supply of Bavarian Nordic’s non-replicating smallpox vaccine Imvamune on Friday.
Imvamune is being developed as a smallpox vaccine for... Read More »
Many U.S. mid-cap companies are struggling to defend themselves against cyber attacks, begging the question of what is the appropriate role the federal government should play in getting the private sector cyber ready, according to Michael Balboni, president of RedLand Strategies, Inc., a business... Read More »
Battelle is set to showcase its new anti-Unmanned Aircraft Systems (UAS) device, DroneDefender, along with other new technologies at the Sea Air Space Show from May 16-18.
DroneDefender is the first man-portable system to provide critical security protection against small UAS devices. The... Read More »
The U.S. Department of Health and Human Services (HHS) announced on Monday that one of the nation’s Centers for Innovation in Advanced Development and Manufacturing (CIADM) will support the development of NasoShield, a second-generation anthrax vaccine.
“Anthrax remains a material threat to... Read More »
The National Institute of Allergy and Infectious Diseases (NIAID) on Friday exercised an option for RiVax, Soligenix, Inc.’s new heat-stable ricin vaccine.
Terms of the agreement are to advance the development of Soligenix’s thermostabilization technology, ThermoVax, combined with the... Read More »
Northtrop Grumman Corp., in collaboration with King Saud University in Riyadh, hosted its second annual cybersecurity competition last week.
The competition, known as CyberArabia, was designated for students across Saudi Arabia’s universities. The program is part of the company’s goal of... Read More »
A new study commissioned by the Aerospace Industries Association (AIA) from business information firm IHS, Inc., was released on Monday highlighting the positive impact that the aerospace and defense industry has on the American economy.
“This new study demonstrates definitively that... Read More »
Raytheon Company on Monday increased deliveries of its small unmanned aircraft systems (UAS) in response to growing warfighter demand.
Raytheon also formed a new UAS directorate within the advanced missile systems product line that combines small UAS airframe and integration with mission... Read More »
Smiths Detection, Inc., announced on Wednesday that it has received a $17.2 million follow-on production order from the U.S. Army as part of the Department of Defense’s Joint Chemical Agent Detector (JCAD) program.
Smiths Detection's Lightweight Chemical Detector (LCD) product line serves as... Read More »
The Center for Strategic and International Studies (CSIS) released a feature-length documentary on Friday entitled “Ebola in America: Epidemic of Fear,” based on the timeline of the Ebola crisis and how the United States responded to the virus.
The documentary contains interviews from those... Read More »
Bavarian Nordic A/S recently published the results of a Phase I trial of a preventive Ebola vaccine regimen in the latest edition of JAMA: The Journal of the American Medical Association
The regimen was undertaken by healthy volunteers who generally responded well to the vaccine, according to... Read More »
